Form 4: Scotts Miracle-Gro Director Reports Stock Transaction

Sentiment:

Insider Transaction Report


David C. Evans, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.

Summary

  • David C. Evans, a Director at The Scotts Miracle-Gro Company (SMG), reported a transaction on June 5, 2026.
  • The transaction involved the acquisition of 121 dividend equivalent rights (DERs).
  • These DERs are economically equivalent to common shares of the issuer.
  • Following this transaction, Mr. Evans beneficially owns 673 common shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to equity compensation rather than a significant strategic event or financial performance indicator.

Positives

  • Director David C. Evans acquired 121 dividend equivalent rights, indicating continued alignment with the company's performance.
  • The acquisition of DERs suggests a potential future increase in beneficial ownership of common shares.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. The acquisition of dividend equivalent rights suggests a positive outlook on the company's future performance as these rights are tied to the value of common shares.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The acquisition of dividend equivalent rights by a director is a common practice for aligning executive and director interests with shareholders, particularly in companies with equity-based compensation plans.

Stakeholder Impact

  • Shareholders: The transaction reinforces the alignment of director compensation with shareholder value, as dividend equivalent rights are tied to the company's stock performance.

Key Dates

DateDescription
06/05/2026Earliest transaction date and transaction date for dividend equivalent rights acquisition.
06/09/2026Date of report signature.

Keywords

Form 4, SEC Filing, Scotts Miracle-Gro, SMG, Director Transaction, Beneficial Ownership, Dividend Equivalent Rights, Common Shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.